Announcements Trials

Browse Landscape

Status

Completed 6 Unknown 2 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Frailty 3 Ovarian Neoplasms 2 Treatment Adherence and Compliance 1 Sarcopenia 1 Prostatic Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, B-Cell 1 Lymphoma 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematologic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

pembrolizumab 38 Blood Specimen Collection 38 Bevacizumab 22 Surveys and Questionnaires 18 Standard of Care 18 Radiotherapy 17 Exercise 17 Carboplatin 17 Nivolumab 15 atezolizumab 14 Paclitaxel 14 Cisplatin 14 Drug Therapy 13 Fluorouracil 12 Cyclophosphamide 12 Cetuximab 11 Trastuzumab 10 Pemetrexed 10 Leucovorin 10 Docetaxel 10 Dexamethasone 10 Oxaliplatin 9 Biopsy 9 pertuzumab 8 olaparib 8 Temozolomide 8 Panitumumab 8 Observation 8 Irinotecan 8 abemaciclib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Geriatric Assessment × Clear all

NCT06572735 2026-02-23

PARIB-OLD-PRO²

Hospices Civils de Lyon

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡